Mechanisms and markers of airway inflammation in cystic fibrosis.
about
Pathophysiologic consequences following inhibition of a CFTR-dependent developmental cascade in the lung2-hydroxy arachidonic acid: a new non-steroidal anti-inflammatory drugCharacterizing Lung Disease in Cystic Fibrosis with Magnetic Resonance Imaging and Airway Physiology.Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosisEvaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase.Cell-bound IL-8 increases in bronchial epithelial cells after arylsulfatase B silencing due to sequestration with chondroitin-4-sulfate.In vitro inhibition of human neutrophil histotoxicity by ambroxol: evidence for a multistep mechanism.Inflammatory markers of lung disease in adult patients with cystic fibrosis.Neutrophil histamine contributes to inflammation in mycoplasma pneumonia.Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography.Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases.Cystic fibrosis and neonatal screening.Stem cell therapy for cystic fibrosis: current status and future prospects.Vitamin D treatment modulates immune activation in cystic fibrosis.Expression of microRNA-93 and Interleukin-8 during Pseudomonas aeruginosa-mediated induction of proinflammatory responses.Virulence factors of Staphylococcus aureus induce Erk-MAP kinase activation and c-Fos expression in S9 and 16HBE14o- human airway epithelial cells.Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice.A low dimensional dynamical model of the initial pulmonary innate response to infection.Genetic Deletion and Pharmacological Inhibition of PI3K γ Reduces Neutrophilic Airway Inflammation and Lung Damage in Mice with Cystic Fibrosis-Like Lung Disease.Increased soluble CD40 ligand levels in cystic fibrosis.Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis.Airway inflammation and infection in congenital bilateral absence of the vas deferens.Airway Epithelium Dysfunction in Cystic Fibrosis and COPD.Therapeutic potentials of superoxide dismutase.
P2860
Q24807258-4032F577-E3E7-43AB-9F09-EA574E01E387Q28535742-18EEF99E-6582-4E37-B76A-459F64375A1DQ31110246-2132D606-E862-4BB3-897D-AD58BDA9C8DDQ33877139-37DCB243-31C7-49EB-8A77-9B03F022F3FAQ34479408-FD49CB82-4785-4203-96A3-7CD27C2AF65FQ34974247-D36BB906-4355-4C93-90EC-5030979E4EB1Q35045796-5F70F9A5-797F-4B20-BB00-6E65F7F9A173Q35749974-6D6FD560-451A-492B-A575-CF8EC6E78CF7Q36228230-B296D218-6F17-4DEF-9FA5-294F33321A03Q37144524-7DE209C9-B0C6-481D-A474-99303369B35CQ37165144-9B9CB8A4-FFA5-4222-9765-4F598042A8F0Q37271670-15DC2335-38DB-4775-A7A2-4655D5FC58BAQ37754873-C33DCC89-105F-4000-B052-ACDF8F9AAFAFQ38805531-8B5178FD-7B47-438E-8AA4-9E203B455AD1Q39033925-581FB8FE-7377-4ED0-96A6-18A831012AF5Q39903246-7F658BDD-24E7-4AB2-89E4-2A0A490D2414Q40175734-BB756F1B-865F-4E25-BCFB-3666592174A4Q40844985-F362FCD2-886F-4329-8E1D-658204DBC160Q41431296-3F9F0C90-1096-4BA5-940B-05F40321B5A5Q44854404-F37EB79A-C0EB-47E6-B5E5-256BB8921FACQ45091453-EE7637C8-4E1F-4DBF-B708-BBBB22C8E931Q47449899-9679B8E9-A3FE-4DCE-8B9B-5CF9B9B361EEQ54970130-6EF63628-901B-4A07-98F7-3BBA391DAF94Q55065624-EE725AC2-3E94-4595-8C16-0A046C36D992
P2860
Mechanisms and markers of airway inflammation in cystic fibrosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mechanisms and markers of airway inflammation in cystic fibrosis.
@ast
Mechanisms and markers of airway inflammation in cystic fibrosis.
@en
Mechanisms and markers of airway inflammation in cystic fibrosis.
@nl
type
label
Mechanisms and markers of airway inflammation in cystic fibrosis.
@ast
Mechanisms and markers of airway inflammation in cystic fibrosis.
@en
Mechanisms and markers of airway inflammation in cystic fibrosis.
@nl
prefLabel
Mechanisms and markers of airway inflammation in cystic fibrosis.
@ast
Mechanisms and markers of airway inflammation in cystic fibrosis.
@en
Mechanisms and markers of airway inflammation in cystic fibrosis.
@nl
P1476
Mechanisms and markers of airway inflammation in cystic fibrosis.
@en
P2093
P304
P356
10.1183/09031936.02.00229202
P577
2002-02-01T00:00:00Z